Chen Guangnan, Fang Tingting, Huang Zhongming, Qi Yiying, Du Shaohua, Di Tuoyu, Lei Zhong, Zhang Xiangyu, Yan Weiqi
Department of Orthopedic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, P.R. China.
Cell Physiol Biochem. 2016;38(2):598-608. doi: 10.1159/000438653. Epub 2016 Feb 5.
BACKGROUND/AIMS: MicroRNAs (miRNAs) are a class of small noncoding RNAs that regulate gene expression by repressing translation or cleaving RNA transcripts in a sequence-specific manner. Downregulated microRNAs and their roles in cancer development have attracted much attention. A growing body of evidence showed that microRNA-133a (miR-133a) has inhibitory effects on cell proliferation, migration, invasion, and metastasis of osteosarcoma.
MiR-133a expression in human osteosarcoma cell lines and human normal osteoblastic cell line hFOB was investigated by real-time PCR (RT-PCR). The role of miR-133a in human osteosarcoma growth and invasion was assessed in cell lines in vitro and in vivo. Then, luciferase reporter assay validated IGF-1R as a downstream and functional target of miR-133a, and functional studies revealed that the anti-tumor effect of miR-133a was probably due to targeting and repressing of IGF-1R expression.
MiR-133a was lower expressed in human osteosarcoma cell lines than human normal osteoblastic cell line hFOB and its effect on inhibiting proliferation, invasion and metastasis is mediated by its direct interaction with the IGF-1R. Furthermore, the tumour-suppressive function of miR-133a probably contributed to inhibiting the activation AKT and ERK signaling pathway.
MiR-133a suppresses osteosarcoma progression and metastasis by targeting IGF-1R in human osteosarcoma cells, providing a novel candidate prognostic factor and a potential anti-metastasis therapeutic target in osteosarcoma.
背景/目的:微小RNA(miRNA)是一类小的非编码RNA,通过以序列特异性方式抑制翻译或切割RNA转录本来调节基因表达。下调的微小RNA及其在癌症发展中的作用已引起广泛关注。越来越多的证据表明,微小RNA-133a(miR-133a)对骨肉瘤细胞的增殖、迁移、侵袭和转移具有抑制作用。
通过实时PCR(RT-PCR)研究miR-133a在人骨肉瘤细胞系和人正常成骨细胞系hFOB中的表达。在体外和体内细胞系中评估miR-133a在人骨肉瘤生长和侵袭中的作用。然后,荧光素酶报告基因检测验证胰岛素样生长因子1受体(IGF-1R)是miR-133a的下游功能靶点,功能研究表明miR-133a的抗肿瘤作用可能是由于靶向并抑制IGF-1R的表达。
miR-133a在人骨肉瘤细胞系中的表达低于人正常成骨细胞系hFOB,其对增殖、侵袭和转移的抑制作用是通过与IGF-1R的直接相互作用介导的。此外,miR-133a的肿瘤抑制功能可能有助于抑制AKT和ERK信号通路的激活。
miR-133a通过靶向人骨肉瘤细胞中的IGF-1R抑制骨肉瘤的进展和转移,为骨肉瘤提供了一种新的候选预后因子和潜在的抗转移治疗靶点。